0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.28%
Revenue growth under 50% of 0425.HK's 23.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.80%
Gross profit growth under 50% of 0425.HK's 33.76%. Michael Burry would be concerned about a severe competitive disadvantage.
85.33%
EBIT growth above 1.5x 0425.HK's 50.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
85.33%
Operating income growth above 1.5x 0425.HK's 50.25%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
87.44%
Net income growth above 1.5x 0425.HK's 4.40%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
62.43%
EPS growth above 1.5x 0425.HK's 3.57%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
62.43%
Diluted EPS growth above 1.5x 0425.HK's 3.57%. David Dodd would see if there's a robust moat protecting these shareholder gains.
15.43%
Share count expansion well above 0425.HK's 0.11%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
15.37%
Diluted share count expanding well above 0425.HK's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-698.01%
Negative OCF growth while 0425.HK is at 153.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-308.72%
Negative FCF growth while 0425.HK is at 155.40%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
11795.63%
10Y revenue/share CAGR above 1.5x 0425.HK's 592.83%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-12.09%
Negative 5Y CAGR while 0425.HK stands at 111.38%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-5.77%
Negative 3Y CAGR while 0425.HK stands at 88.86%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-9561.15%
Negative 10Y OCF/share CAGR while 0425.HK stands at 258.99%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-664.88%
Negative 5Y OCF/share CAGR while 0425.HK is at 90.54%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1361.38%
Negative 3Y OCF/share CAGR while 0425.HK stands at 140.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
233.13%
Net income/share CAGR at 75-90% of 0425.HK's 265.10%. Bill Ackman would press for strategic moves to boost long-term earnings.
384.15%
5Y net income/share CAGR above 1.5x 0425.HK's 52.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-14.85%
Negative 3Y CAGR while 0425.HK is 60.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
149.37%
5Y equity/share CAGR above 1.5x 0425.HK's 62.10%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
62.96%
3Y equity/share CAGR above 1.5x 0425.HK's 31.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-18.74%
Firm’s AR is declining while 0425.HK shows 24.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
30.58%
Inventory growth well above 0425.HK's 3.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.55%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.59%
Under 50% of 0425.HK's 7.13%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-99.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-35.78%
Our R&D shrinks while 0425.HK invests at 16.89%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-46.41%
We cut SG&A while 0425.HK invests at 18.08%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.